Novartis' Pluvicto shown to slow prostate cancer in earlier setting
FRANKFURT (Reuters) -Novartis said on Monday that its targeted radiotherapy Pluvicto was shown to sl...
2nd June, 2025
FRANKFURT (Reuters) -Novartis said on Monday that its targeted radiotherapy Pluvicto was shown to sl...
2nd June, 2025
PARIS (Reuters) -The French state has made a 410 million euros ($466.33 million)confirmatory offer t...
2nd June, 2025
PARIS (Reuters) - Dior is appointing its menswear designer Jonathan Anderson to also head womenswear...
2nd June, 2025
PARIS (Reuters) -French pharma group Sanofi has agreed to buy US-based Blueprint Medicines Corporati...
2nd June, 2025
By Ahmed Eljechtimi RABAT (Reuters) -Britain's foreign minister, David Lammy, said on Sunday that th...
1st June, 2025
By Julie Steenhuysen CHICAGO (Reuters) -Treating breast cancer patients with AstraZeneca's experimen...
1st June, 2025
By Julien Pretot PARIS (Reuters) -When Luis Enrique claimed in early 2024 that Paris St Germain woul...
31st May, 2025
By Deena Beasley (Reuters) -Gilead Sciences' Trodelvy in combination with Merck's blockbuster immuno...
31st May, 2025
By Enrico Sciacovelli ROME (Reuters) -Europe's largest film studio Cinecitta is aiming to re-launch...
31st May, 2025
By Xinghui Kok SINGAPORE (Reuters) -Chinese efforts to spy on the Dutch are intensifying, with the f...
31st May, 2025
By Anna Tong, Jeffrey Dastin SAN FRANCISCO (Reuters) -Artificial intelligence developer Anthropic is...
30th May, 2025
STOCKHOLM (Reuters) - If Anna Anerfalt gets a license to sell gin, whiskey and schnapps to visitors...
30th May, 2025